Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Dosing Comparison in Moderate Persistent Asthma
NCT01152450Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised, double-blind trial of tiotropium in asthma (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Forced Expiratory Volume in One Second Area Under the Curve 0-24 Hours at 4 weeks. Started Jul 2010; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01152450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01152450.